Cargando…
Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441271/ http://dx.doi.org/10.1186/1742-4690-9-S2-O56 |
| _version_ | 1782243251873382400 |
|---|---|
| author | Goepfert, P Elizaga, M Montefiori, D Hural, J DeRosa, S Tomaras, G Seaton, K Sato, A Ouedraogo, L Donastorg, Y Cardinali, M Lama, J Baden, L Keefer, M McElrath, J Kalams, S Robinson, H |
| author_facet | Goepfert, P Elizaga, M Montefiori, D Hural, J DeRosa, S Tomaras, G Seaton, K Sato, A Ouedraogo, L Donastorg, Y Cardinali, M Lama, J Baden, L Keefer, M McElrath, J Kalams, S Robinson, H |
| author_sort | Goepfert, P |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3441271 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-34412712012-09-18 Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles Goepfert, P Elizaga, M Montefiori, D Hural, J DeRosa, S Tomaras, G Seaton, K Sato, A Ouedraogo, L Donastorg, Y Cardinali, M Lama, J Baden, L Keefer, M McElrath, J Kalams, S Robinson, H Retrovirology Oral Presentation BioMed Central 2012-09-13 /pmc/articles/PMC3441271/ http://dx.doi.org/10.1186/1742-4690-9-S2-O56 Text en Copyright ©2012 Goepfert et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Oral Presentation Goepfert, P Elizaga, M Montefiori, D Hural, J DeRosa, S Tomaras, G Seaton, K Sato, A Ouedraogo, L Donastorg, Y Cardinali, M Lama, J Baden, L Keefer, M McElrath, J Kalams, S Robinson, H Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles |
| title | Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles |
| title_full | Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles |
| title_fullStr | Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles |
| title_full_unstemmed | Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles |
| title_short | Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles |
| title_sort | phase 2a safety and immunogenicity testing of dna and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441271/ http://dx.doi.org/10.1186/1742-4690-9-S2-O56 |
| work_keys_str_mv | AT goepfertp phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT elizagam phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT montefiorid phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT huralj phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT derosas phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT tomarasg phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT seatonk phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT satoa phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT ouedraogol phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT donastorgy phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT cardinalim phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT lamaj phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT badenl phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT keeferm phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT mcelrathj phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT kalamss phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles AT robinsonh phase2asafetyandimmunogenicitytestingofdnaandrecombinantmodifiedvacciniaankaravirusvaccinesexpressingviruslikeparticles |